1,425 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
CA Botana International recalled 470 tubes of Doctor D. Schwab Controlling Cream on October 10, 2025. The recall stems from CGMP deviations that pose a high hazard risk. Consumers should stop using the product and seek guidance from healthcare providers.
CA BOTANA recalled 555 tubes of Doctor D. Schwab Controlling Balm on October 10, 2025, due to CGMP deviations. The affected product contains salicylic acid and tea tree oil. Consumers should stop using the balm immediately and contact CA BOTANA International for guidance.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg on October 10, 2025, due to failed stability testing. The recall affects capsules packaged in blister packs and sold nationwide. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Doctor D. Schwab recalled 805 tubes of Shimmery Sun Lotion Sunscreen SPF 30 on October 10, 2025. The recall follows significant deviations from current good manufacturing practices (CGMP). Consumers should stop using the product immediately and contact CA BOTANA for guidance.
CA Botana International recalled 1,167 tubes of Doctor. D. Schwab Mineral Sunscreen SPF 50 on October 10, 2025. The recall stems from current good manufacturing practices (CGMP) deviations. Affected products include Lot Code D54596 with an expiration date of January 31, 2028.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.
CLEARSTEM recalled 4,890 bottles of YOU ARE SUNSHINE SPF 50 sunscreen on October 10, 2025. The recall follows concerns over CGMP deviations. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Doctor D. Schwab recalled 810 tubes of Clinical Weh Weh Natural Pain Relief Gel on October 10, 2025. The recall stems from CGMP deviations that could compromise product safety. The affected product was distributed in California, Colorado, Florida, Puerto Rico, and Washington.
CA Botana International, Inc. recalled 874 tubes of Ultra Umbrella Sunscreen SPF 30 on October 10, 2025. The recall stems from CGMP deviations that may affect product safety. Consumers in CA, CO, FL, PR, and WA should stop using the product immediately.
VitaTienda Co U.S.A. recalled 3,295 bottles of Elixir by Coco March Mineral Sunscreen SPF 50 on October 10, 2025. The recall stems from CGMP deviations that could affect product safety. Consumers should stop using the sunscreen immediately and contact their healthcare provider for guidance.
CA Botana International recalled 1,401 tubes of Doctor D. Schwab Flawless Skin Fluid Tinted Moisturizer on October 10, 2025. The product may not meet current Good Manufacturing Practices (CGMP). Consumers should stop using it immediately and contact the company for guidance.
Dr. Bump Natural Pain Relief Gel has been recalled due to CGMP deviations. 4,890 bottles are affected, distributed in California, Colorado, Florida, Puerto Rico, and Washington. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
Mylan Institutional LLC recalled 800 vials of Haloperidol Lactate Injection on October 10, 2025, due to incorrect RFID tag labels. The product may pose a risk due to potential mislabeling affecting tracking and administration. Healthcare providers should stop using the product immediately and follow up with Safecor Health for guidance.
Thoratec recalled 8,399 CentriMag Blood Pumps on October 10, 2025, due to a significant malfunction risk. The blood pump may not securely lock into the motor, potentially leading to serious health complications. The recall affects models distributed worldwide, including across the United States and several countries.
STAQ Pharma Inc. recalled Ketamine Hydrochloride 50mg/5 mL syringes on October 9, 2025. The recall affects products with incorrect or missing lot and expiration dates. The FDA classified this recall as Class III due to potential risks to patient safety.
Pivotal Health Solutions recalled 34 heated massage tables on October 9, 2025. The heat function may overheat, posing a risk of smoldering and melting. Affected units are distributed nationwide in the U.S., Canada, and Japan.
STAQ Pharma Inc. recalled FentaNYL Citrate PF on October 9, 2025, due to incorrect or missing lot and expiration dates. The injection, distributed nationwide, poses a high hazard risk. Consumers and healthcare providers should stop using the product immediately.
STAQ Pharma Inc. recalled Hydromorphone HCL PF injections on October 9, 2025, due to incorrect or missing lot and expiration dates. The recall affects products distributed nationwide across the U.S. Healthcare providers and consumers must immediately cease using the affected medication.
USV Private recalled 8,952 bottles of Olopatadine Hydrochloride Ophthalmic Solution on October 9, 2025. The solution exceeded impurity specifications, posing a health risk. Consumers should stop using the product immediately and contact their healthcare provider.
Taoscare recalled 3 boxes of motion sickness patches on October 9, 2025. The product was marketed without an approved NDA/ANDA. Consumers should stop using the patches immediately and seek guidance.
C-RAD POSITIONING AB recalled 189 Catalyst and Catalyst+ devices on October 9, 2025, due to issues with stereotactic radiosurgery (SRS) treatment. The defect may lead to incorrect patient positioning, potentially compromising treatment effectiveness. The recall affects devices distributed across 37 countries, including the United States.
American Health Packaging recalled 27,868 blister packs of Sucralfate Tablets on October 9, 2025. The company filed for Chapter 11 bankruptcy, impairing its ability to monitor product quality. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Glycar SA Pty. recalled 18 units of the SJM Pericardial Patch on October 9, 2025. The affected lot may not meet required tensile strength specifications. Healthcare providers and patients should stop using this device immediately.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.